Stock Titan Trading tools for traders and investors.

-

08:37:53 AM

Last JAGX Stock Market News

JAGX - Jaguar Health Inc

12/04/20 8:30 AM

NASDAQ : JAGX

Jaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter into Fifth Amendment to the Accounts Receivable Purchase Agreement with Oasis Capital, LLC, Dated May 12, 2020

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Jaguar and its wholly owned subsidiary, Napo Pharmaceuticals,

RHEA-AI

very positive

11/30/20 8:30 AM

NASDAQ : JAGX

Jaguar Health Announces Plan to Develop and Commercialize Crofelemer, the Company's Novel Proprietary Drug, for the Indication of Inflammatory Diarrhea, Initially in 'Long-Hauler' COVID-19 Recovery Patients

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") and the

RHEA-AI

neutral

11/24/20 9:00 AM

NASDAQ : JAGX

Jaguar Health Announces Release of Podcast Interview with The Wall Street Resource

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"), a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI

RHEA-AI

neutral

11/16/20 8:00 AM

NASDAQ : JAGX

Jaguar Health, Inc. Reports 2020 Third Quarter Financial Results

RHEA-AI

negative

11/10/20 4:15 PM

NASDAQ : JAGX

Jaguar Health to Host Investor Call Monday, November 16th at 8:30 a.m. Eastern Regarding Q3 2020 Financials & Business Updates

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that Company management will host a conference call on Monday, November 16, 2020 at 8:30 a.m. Eastern Time to

RHEA-AI

neutral

10/29/20 8:30 AM

NASDAQ : JAGX

Jaguar Health Receives Positive Nasdaq Listing Determination

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that on October 28, 2020 the Company received formal notice that the Nasdaq Hearings Panel (the "Panel") granted Jaguar an extension through December 23, 2020 to

RHEA-AI

neutral

10/20/20 8:30 AM

NASDAQ : JAGX

Reminder: Jaguar Health Hosting Exclusive Virtual Educational Event, "Diarrhea Dialogues: Why Bowel Control is Critical to Supportive Care in Cancer"

Leading Oncologists, Supportive Care Experts, and Patient Advocates Discuss Importance of Supportive Care for Cancer Patients and Address Debilitating Diarrhea Resulting from Cancer Therapy Virtual Event and Q&A 3:00 PM to 4:30 PM EDT on October 20 Registration Open for Financial and Business

RHEA-AI

neutral

10/16/20 4:15 PM

NASDAQ : JAGX

Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today that effective October 13, 2020, the Company has granted nonstatutory stock options for the purchase of up to 45,000 shares of the Company's common stock to one new

RHEA-AI

very positive

10/15/20 8:30 AM

NASDAQ : JAGX

Napo Pharmaceuticals, a Subsidiary of Jaguar Health, Launches Web-based NapoCares Platform to Enhance Patient Access to Mytesi

Jaguar Health, Inc. (NASDAQ:JAGX) announced today that its wholly owned subsidiary, Napo Pharmaceuticals, Inc.

RHEA-AI

very positive

10/14/20 8:30 AM

NASDAQ : JAGX

Jaguar Health and Its Subsidiary Bolster Management Team with Appointment of Melissa Yeager, J.D. as Senior Vice President, Regulatory Affairs & Quality Assurance

RHEA-AI

very positive

Prev 1 2 3 4 5 Next